Philogen S.p.A. (BIT:PHIL)
Italy · Delayed Price · Currency is EUR 21.25
+0.05 (0.24%)
Apr 17, 2026, 10:35 AM CET
Philogen Revenue
In the year 2025, Philogen had annual revenue of 319.73M EUR with 313.81% growth. Philogen had revenue of 311.20M in the half year ending December 31, 2025, with 12,856.04% growth.
Revenue
319.73M
Revenue Growth
+313.81%
P/S Ratio
2.67
Revenue / Employee
1.59M
Employees
201
Market Cap
853.96M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 319.73M | 242.47M | 313.81% |
| Dec 31, 2024 | 77.26M | 52.53M | 212.42% |
| Dec 31, 2023 | 24.73M | -2.21M | -8.20% |
| Dec 31, 2022 | 26.94M | 21.98M | 442.71% |
| Dec 31, 2021 | 4.96M | -1.38M | -21.77% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Recordati Industria Chimica e Farmaceutica | 2.62B |
| Amplifon | 2.40B |
| DiaSorin | 1.20B |
| Safilo Group | 983.38M |
| EL.En. | 590.85M |
| GPI S.p.A. | 546.18M |
| Garofalo Health Care | 485.12M |
| Svas Biosana | 134.95M |